Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT01196832

Role of Fibrocytes in Chronic Obstructive Pulmonary Disease

Conditions: Chronic Obstructive Pulmonary Disease

Sex: All
Ages: 40 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 115
Sponsor: University Hospital, Bordeaux

Location: CHU de Bordeaux Pessac

Summary

Chronic obstructive pulmonary disease (COPD) is a frequent airway disease characterized by both bronchial inflammation and remodelling. Bronchial mucosa is infiltrated by macrophages, neutrophils and lymphocytes. In addition, the number of eosinophils can be also increased during exacerbation. Airway remodelling is an abnormal tissue repair following bronchial inflammation, which contributes to none reversible pathological features, such as bronchial and peri-bronchial fibrosis. It also influences the prognosis of COPD and its mechanisms remain largely unknown. The role of fibrocytes has been demonstrated in the pathophysiology of asthma, lung fibrosis or pulmonary hypertension. However, the recruitment of blood fibrocytes and their involvement in COPD airway remodelling remain unknown.

Eligibility Criteria

Inclusion Criteria: * Patients: diagnostic of Chronic obstructive pulmonary disease (COPD) exacerbation. * Control group: subjects without any history of lung disease and with normal lung function testing. Subjects will be separated in 2 sub-groups according to smoking history (Never smokers, smokers (former or current) and paired to patients according to age and sex. * Written informed consent Exclusion Criteria: * Subject without any social security or health insurance * Asthma, lung fibrosis or idiopathic pulmonary hypertension * Chronic viral infections (hepatitis, HIV)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT01196832). StuddyBuddy aggregates publicly available trial information.